Bristol-Myers Squibb/BMY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Bristol-Myers Squibb
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Ticker
BMY
Sector
Healthcare
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Princeton, United States
Employees
34,100
Website
www.bms.com
BMY Metrics
BasicAdvanced
$84B
Market cap
-
P/E ratio
-$3.00
EPS
0.43
Beta
$2.34
Dividend rate
5.67%
Dividend yield
Price and volume
Market cap
$84B
Beta
0.43
Dividend rate
$2.34
Financial strength
Current ratio
1.11
Quick ratio
0.919
Long term debt to equity
308.787
Total debt to equity
347.214
Dividend payout ratio (TTM)
-77.42%
Interest coverage (TTM)
6.41%
Management effectiveness
Return on assets (TTM)
5.39%
Return on equity (TTM)
-25.33%
Valuation
Price to revenue (TTM)
1.86
Price to book
5.08
Price to tangible book (TTM)
-2.2
Price to free cash flow (TTM)
6.77
Dividend yield (TTM)
5.67%
Growth
Revenue change (TTM)
-0.68%
Earnings per share change (TTM)
-187.57%
3-year revenue growth
2.08%
3-year earnings per share growth
2.80%
3-year dividend per share growth
7.57%
What the Analysts think about BMY
Analyst Ratings
Majority rating from 27 analysts.
BMY Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$12B
3.38%
Net income
-$12B
-775.99%
Profit margin
-100.38%
-753.94%
BMY Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.75
$2.00
$1.70
-$4.40
-
Expected
$1.98
$1.76
$1.53
-$4.44
$1.70
Surprise
-11.43%
13.64%
11.13%
-0.80%
-
BMY News
AllArticlesVideos
Bristol-Myers Squibb dragged down the S&P 500 this earnings season
Yahoo Finance·2 months ago
Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)
Seeking Alpha·2 months ago
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
Jul
5
Bristol-Myers Squibb
Dividend·Ex-dividend
Aug
1
Bristol-Myers Squibb
Dividend·Payment
$0.60
Per share
FAQs
What’s the current market cap for Bristol-Myers Squibb stock?
Bristol-Myers Squibb (BMY) has a market cap of $84B as of July 03, 2024.
What is the P/E ratio for Bristol-Myers Squibb stock?
The price to earnings (P/E) ratio for Bristol-Myers Squibb (BMY) stock is 0 as of July 03, 2024.
Does Bristol-Myers Squibb stock pay dividends?
Yes, the Bristol-Myers Squibb (BMY) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $2.34 and the yield is 5.67%. Bristol-Myers Squibb has a payout ratio of -77.42% on a trailing twelve-month basis.
When is the next Bristol-Myers Squibb dividend payment date?
The next Bristol-Myers Squibb (BMY) dividend payment is scheduled for August 01, 2024.
What is the beta indicator for Bristol-Myers Squibb?
Bristol-Myers Squibb (BMY) has a beta rating of 0.43. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Bristol-Myers Squibb stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.